GLP1R and hyperlipidemia: Key baseline characteristics—such as T2DM (42%), smoking (8%), hypertension (79%), hyperlipidemia (50.8%), and GLP-1 receptor agonist use (5.8%)—were well balanced between the two groups (Table 1).